Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor
- PMID: 2533958
Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor
Abstract
Human adenoviruses are providing insights into strategies that viruses may adopt to evade immune surveillance. There are 47 serotypes that form six groups (A to F) with different genetic and biological properties. Adenovirus type 2 (Ad2) and Ad5, two group C types, the most common and best understood in terms of molecular biology, cause respiratory infections in young children and often form persistent infections. Following infection, the linear duplex DNA genome is expressed in two broad phases: "early", when viral proteins function to usurp the cell; and "late", when viral DNA and structural proteins are synthesized and virions are assembled. One of the early transcription units, region E3, encodes two proteins that appear to counteract different branches of the host's anti-viral defenses. A 19,000 Mr protein called gp19K protects cells against cytolysis by adenovirus-specific cytotoxic T lymphocytes (CTL). Gp19K has two properties that are crucial to this function: it is localized in the endoplasmic reticulum, and it binds strongly to class I antigens of the major histocompatibility complex (MHC). The effect of these two properties is to block transport of class I antigens to the cell surface. In order to lyse adenovirus-infected cells, CTL must recognize adenovirus peptide antigens complexed with class I major histocompatability complex antigens displayed on the cell surface. Since gp19K prevents this, it renders the cell effectively invisible to CTL. The second anti-immune E3 protein is a 14,700 Mr protein called 14.7K. The 14.7K protects adenovirus-infected cells against cytolysis by tumor necrosis factor (TNF). TNF is a pleiotropic immunoregulatory protein that has anti-viral properties and is believed to provide a defense against virus infections. The 14.7K presumably counteracts the anti-viral effects of TNF in vivo. The mechanism of action of the 14.7K is unknown. Further studies on gp19K and 14.7K should assist our understanding of the immune system and adenovirus pathogenesis.
Similar articles
-
Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K.J Immunol. 1989 Sep 15;143(6):2031-7. J Immunol. 1989. PMID: 2789254
-
The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.J Immunol. 1990 Nov 1;145(9):3080-6. J Immunol. 1990. PMID: 2145367
-
Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor.J Immunol. 1989 Dec 15;143(12):4193-200. J Immunol. 1989. PMID: 2531778
-
Adenovirus genes that modulate the sensitivity of virus-infected cells to lysis by TNF.J Cell Biochem. 1993 Dec;53(4):329-35. doi: 10.1002/jcb.240530410. J Cell Biochem. 1993. PMID: 8300750 Review.
-
[MHC tetramers: tracking specific immunity].Acta Med Croatica. 2003;57(4):255-9. Acta Med Croatica. 2003. PMID: 14639858 Review. Croatian.
Cited by
-
mRNA and Adenoviral Vector Vaccine Platforms Utilized in COVID-19 Vaccines: Technologies, Ecosystem, and Future Directions.Vaccines (Basel). 2023 Nov 21;11(12):1737. doi: 10.3390/vaccines11121737. Vaccines (Basel). 2023. PMID: 38140142 Free PMC article. Review.
-
Characterization of mutants within the gene for the adenovirus E3 14.7-kilodalton protein which prevents cytolysis by tumor necrosis factor.J Virol. 1993 Apr;67(4):2159-67. doi: 10.1128/JVI.67.4.2159-2167.1993. J Virol. 1993. PMID: 8445725 Free PMC article.
-
The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.J Virol. 1996 Aug;70(8):4904-13. doi: 10.1128/JVI.70.8.4904-4913.1996. J Virol. 1996. PMID: 8763993 Free PMC article.
-
Adenovirus vector-infected cells can escape adenovirus antigen-specific cytotoxic T-lymphocyte killing in vivo.J Virol. 1997 Jul;71(7):5189-96. doi: 10.1128/JVI.71.7.5189-5196.1997. J Virol. 1997. PMID: 9188586 Free PMC article.
-
The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats.J Exp Med. 1998 Sep 7;188(5):877-86. doi: 10.1084/jem.188.5.877. J Exp Med. 1998. PMID: 9730889 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials